KRAS and myelodysplastic syndrome: MDS patients can also carry mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS) and the neuroblastoma RAS viral oncogene homolog (NRAS), which are involved in MAPK signal transduction pathway.